Single Nucleotide Polymorphism of TCF7L2 and Adiponectin Genes for Type 2 Diabetes Mellitus in Taiwan

Fooyin Journal of Health Sciences

Volumn 1, Issue 1, 2009, Pages 41-47

  Tsao, Der An ^a,b   Huang, Chiung Wen ^b   Chang, Huoy Rou ^c   Hsieh, Kun Chung ^b   Tung, Ting Chen ^b   Liao, Min Chiao ^a   Huang, Shao Chou ^d   Lu, Tung Yu ^e   Huang, Ching Shan ^f  

^a FOOYIN UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL UNITED HOSPITAL   (Taiwan)

^e Kaohsiung Medical Center   (Taiwan)

^f Central Taiwan University   (Taiwan)

Author keywords

adiponectin; PCR RFLP; polymorphism; T2DM; TCF7L2

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CHROMOSOME 10Q; CHROMOSOME 3Q; CONTROLLED STUDY; FEMALE; GENE; GENE LOCATION; GENE MAPPING; GENOME; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION FACTOR 7 LIKE 2 GENE;

EID: 71649088396     PISSN: 18778607     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1877-8607(09)60007-2     Document Type: Article

References (27)

1. Despres J.P. Health consequences of visceral obesity. Ann Med 33 (2001) 534-541
2. Saxena R., Gianniny L., Noël P., et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55 (2006) 2890-2895
3. Grant S.F., Thorleifsson G., Reynisdottir I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 (2006) 320-323
4. Yi F., Brubaker P.L., and Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280 (2005) 1457-1464
5. Coleen M., Damcott, Toni I., et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish. Diabetes 55 (2006) 2654-2659
6. Cauchi S., Meyre D., Dina C., et al. Transcription factor TCF7L2 genetic study in the French population. Diabetes 55 (2006) 2903-2908
7. Florez J.C., Jablonski K.A., Bayley N., et al., for the Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355 (2006) 241-250
8. Hattersley A.T. Prime suspect: the TCF7L2 gene and type 2 diabetes risk. J Clin Investig 117 (2007) 2077-2079
9. White R.T., Damm D., Hancock N., et al. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 267 (1992) 9210-9213
10. Hotamisligil G.S., Arner P., Caro J.F., et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
11. Halaas J.L., Gajiwala K.S., Maffei M., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
12. Maeda K., Nishida M., Kihara S., et al. cDNA cloning and expression of a novel adipose specific collagen like factor apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
13. Nakano Y., Tobe T., Choi-Miura N.H., et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 120 (1996) 803-812
14. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
15. Scherer P.E., Williams S., Fogliano M., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
16. Havel P.J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13 (2002) 51-59
17. Yokota T., Oritani K., Takahashi I., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
18. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophy Res Commun 257 (1999) 79-83
19. Zoccali C., Mallamaci F., and Tripepi G. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
20. Matsuzawa Y., Funahashi T., and Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892 (1999) 146-154
21. Comuzzie A.G., Funahashi T., and Sonnenberg G. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metabol 86 (2001) 4321-4325
22. MacDougald O.A., and Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol Metabol 13 (2002) 5-11
23. Stefan N., Bunt J.C., and Salbe A.D. Plasma adiponectin concentrations in children: relationship with obesity and insulinemia. J Clin Endocrinol Metab 87 (2002) 4652-4656
24. Nemet D., Wang P., and Funahashi T. Adipocytokines, body composition, and fitness in children. Pediatr Res 53 (2003) 148-152
25. Smith U. TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia 50 (2006) 5-7
26. Zeggini E., and McCarthy M.I. TCF7L2: the biggest story in diabetes genetics since HLA?. Diabetologia 50 (2007) 1-4
27. Gu H.F., Abulaiti A., Ostenson C.G., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53 (2004) 31-35